OurHealthNetwork.com


Home
About Us
Ask Our Doctor
Arthritis
Back Pain & Products
Foot Pain & Products
Hand/Wrist/Elbow Pain
Knee Pain & Products
Obesity
Medical Products Store
Your Shopping Cart
Testimonials
Privacy Policy
Contact Us



Recommend this site!

Subscribe to our newsletter!

Over-The-Counter Items

Royce - Exoform Ankle Brace



ADVANCED TECHNOLOGY RESULTS IN BREAKTHROUGH PERFORMANCE

Exoformô Technology forms an injection molded exoskeleton directly onto soft breathable fabric, combining the compression and comfort of a soft ankle brace with the stability of a stirrup ankle brace.

Improves performance 35%. In-house testing shows that the Exoform Ankle Brace reduces ankle inversion by as much as 35% over the leading ankle stirrup. Compared to the leading stabilized soft ankle brace, the Exoform shows a 40% improvement!

Speed laces allow the user to lace up the Exoform in seconds, a big time saver that will encourage use and drive compliance. Slim fit design is low profile and fits easily into a shoe. Injection molded exoskeleton forms a network of support zones strategically placed to minimize inversion and eversion without restricting plantar and dorsi-flexion.

Available with a unique heel-lock strapping system.

Nylon "figure 8" straps will not stretch during exercise. Fully adjustable even while in use.

Breathable lightweight fabric enhances comfort by allowing heat and moisture to escape throughout the brace.

Padded heel and tongue fabric is durable and provides added comfort. Material is 100% latex free.

Machine washable. Air dries quickly.

Bi-lateral design fits left or right ankle.

Size Men's Shoes Size Women's Shoes Size
X-Small 7 and under 6 and under
Small 7 1/2 - 9 6 1/2 - 8
Medium 9 1/2 - 11 8 1/2 - 10
Large 11 1/2 - 13 10 1/2 - 12
X-Large 13 1/2 & up 12 1/2 & up

Price: $38.95


[ Top of page ]

© OurHealthNetwork.com | Privacy Statement
This site is designed, maintained, and hosted by atCommunications, LLC.
Disclaimer and Terms of Service

Customer Service | Media Relations | Investor Relations